{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-09-03T17:42:24.844921+00:00","company":{"ticker":"PHBI","cik":1435181,"company_name":"Pharmagreen Biotech Inc."},"pagination":{"limit":100,"returned":3,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"JanBella Group, LLC.","detail":"equity_purchase","count":1,"first_seen":"2022-12-02T23:59:59+00:00","last_seen":"2022-12-02T23:59:59+00:00","evidence_fact_ids":[193325]}]},"facts":[{"fact_type":"auditor_change","fact_key":"2edcf893c891de2b59a6aa265f35a1479da6f997","cik":1435181,"ticker":"PHBI","company_name":"Pharmagreen Biotech Inc.","filed_at":"2023-05-18T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"Turner, Stone & Company L.L.P.","disagreement_text":null,"effective_date":"2023-05-04","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Pharmagreen Biotech Inc. engaged Turner, Stone & Company L.L.P. as its auditor.","evidence_excerpt":"the Board of Directors of the Company approved the appointment of Turner, Stone & Company L.L.P. (“Turner Stone”) as the Company’s new independent registered public accounting firm, effective immediately","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-23-003695","anchor_url":"https://secwatch.observer/filing/0001477932-23-003695#claim-2edcf893c891de2b59a6aa265f35a1479da6f997","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1435181/000147793223003695/0001477932-23-003695-index.htm"},{"fact_type":"auditor_change","fact_key":"7465ebb3b10816005318cbdea0d9343f5da21333","cik":1435181,"ticker":"PHBI","company_name":"Pharmagreen Biotech Inc.","filed_at":"2023-05-18T23:59:59+00:00","payload":{"action":"resignation","auditor_name":"Sadler, Gibb & Associates, LLC","disagreement_text":null,"effective_date":"2023-04-27","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Sadler, Gibb & Associates, LLC resigned as auditor of Pharmagreen Biotech Inc..","evidence_excerpt":"Pharmagreen Biotech, Inc. (the “Company”) has accepted the resignation of Sadler, Gibb & Associates, LLC (“SGA”) as its independent registered public accounting firm, which resignation was submitted to the Company in a letter dated April 27, 2023","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-23-003695","anchor_url":"https://secwatch.observer/filing/0001477932-23-003695#claim-7465ebb3b10816005318cbdea0d9343f5da21333","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1435181/000147793223003695/0001477932-23-003695-index.htm"},{"fact_type":"material_agreement","fact_key":"943c740d2a98931eae1102a34f5a66924c0fa4b5","cik":1435181,"ticker":"PHBI","company_name":"Pharmagreen Biotech Inc.","filed_at":"2022-12-02T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"JanBella Group, LLC.","effective_date":null,"item_codes_triggered":["1.01"],"value_text":"$50,000"},"claim":"Pharmagreen Biotech Inc. entered into Securities Purchase Agreement with JanBella Group, LLC. valued at $50,000.","evidence_excerpt":"Pharmagreen Biotech, Inc., a (“NV”) corporation (the “Company”) and JanBella Group, LLC. (the “Investor”) have entered into a Securities Purchase Agreement dated as of November 2nd, 2022 (the “Agreement”) providing for the issuance of the Convertible Promissory Note in the principal amount of $50,000","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-22-009028","anchor_url":"https://secwatch.observer/filing/0001477932-22-009028#claim-943c740d2a98931eae1102a34f5a66924c0fa4b5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1435181/000147793222009028/0001477932-22-009028-index.htm"}]}